Posted by ABMN Staff on Mar 29th, 2024
Truist Financial reaffirmed their buy rating on shares of RadNet (NASDAQ:RDNT – Free Report) in a research report released on Thursday, Benzinga reports. The firm currently has a $55.00 target price on the medical research company’s...
More of this article »